To determine whether this novel phosphorylation event is of clinical significance, we performed immunohistochemistry staining with anti‐Plk1 and anti‐p‐DNMT3a antibodies in a human PCa tissue array. The gene discussed is DNMT3A; the disease is posterior cortical atrophy.